Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Antiabortion-Rights Groups To Reintroduce Colorado Personhood Initiative
Colorado Right to Life and Personhood USA are proposing a 2010 state ballot initiative with a different version of 2008"s defeated "personhood" amendment to the state constitution, the Colorado Springs Gazette reports. The groups intend to submit their proposal to the Colorado Legislative Council this week. In the November 2008 election, 73% of state voters opposed the previous version, known as Amendment 48, which was sponsored by Colorado for Equal Rights.The new version includes modified language that its supporters say will clarify its intent. Rather than defining a person as "any human being from the moment of fertilization," the new version would establish personhood as "every human being from the beginning of the biological development of that human being." The initiative"s sponsors also said that they will be better funded and articulate a clearer message than in 2008, when a college student launched the campaign.According to the Gazette, abortion-rights supporters "weren"t overly concerned" about the new initiative. Jacy Montoya, head of the Colorado Organization for Latina Opportunity and Reproductive Rights, said that the 2008 vote demonstrated that Colorado residents are "uncomfortable with the government and strangers making personal decision for families." Lynn Paltrow, executive director of National Advocates for Pregnant Women, said that the new attempt "gives us another opportunity to explain how personhood amendments threaten all pregnant women, including those going to term" (Barna,Colorado Springs Gazette, 6/29).
generic viagra online
Advancing Vaccine Against Valley Fever - UTSA Infectious Disease Researchers
Medical mycologists in The South Texas Center for Emerging Infectious Diseases (STCEID) and the Department of Biology at The University of Texas at San Antonio (UTSA) have significantly advanced the fight against San Joaquin Valley Fever, a respiratory infection of humans, commonly called Valley Fever, which is caused by the Coccidioides fungus. For the first time, the researchers have genetically engineered a live, attenuated vaccine that successfully protects mice against Valley Fever, known in scientific circles as coccidioidomycosis.
News of the day
Siemens To Provide 37 Hospitals And 300 Clinics In South Africa With Healthcare IT Software
The implementation of the Siemens hospital information system is a significant part of the Gauteng
Health Insurance

Advancing Vaccine Against Valley Fever - UTSA Infectious Disease Researchers

Medical mycologists in The South Texas Center for Emerging Infectious Diseases (STCEID) and the Department of Biology at The University of Texas at San Antonio (UTSA) have significantly advanced the fight against San Joaquin Valley Fever, a respiratory infection of humans, commonly called Valley Fever, which is caused by the Coccidioides fungus. For the first time, the researchers have genetically engineered a live, attenuated vaccine that successfully protects mice against Valley Fever, known in scientific circles as coccidioidomycosis. A live, attenuated vaccine is used as a preventative treatment based upon creation of a mutated form of the pathogen that is no longer capable of causing disease. Coccidioides, a soil-dwelling fungus, is responsible for significantly increased numbers of respiratory infections among outdoor workers when compared to the general population. In addition, people with compromised T-cell immunity, the elderly and certain racial groups, such as African-Americans and Filipinos who live in the Southwestern United States, have an increased incidence of the infection"s symptoms, caused by the inhalation of Coccidioides spores. In approximately 40% of human Valley Fever cases, respiratory problems set in one to three weeks after inhalation. Although less than one percent of infected individuals experience severe symptoms, such as chronic-progressive pneumonia or meningitis, the incidence of reported primary pulmonary infection cases in Arizona and California is on the rise, having significantly increased in the last decade. STCEID researchers at UTSA and Wilford Hall Medical Center at San Antonio"s Lackland Air Force Base have long collaborated on Coccidioides studies in the hopes of developing a vaccine to better protect those who are exposed to it in the future. This most recent study has been funded by the National Institute of Allergy and Infectious Diseases, the California HealthCare Foundation and the Margaret Batts Tobin Foundation. "Respiratory infections caused by Coccidioides tend to escape the radar of most large pharmaceutical companies, because only about 100,000 cases are reported each year," said Garry Cole, professor of biology at UTSA and the study"s principal investigator. He adds, "But when I look at 100,000 cases, I see 100,000 faces looking back at me." Christi Fish University of Texas at San Antonio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009